Showing results (121-130 of 209) with videos related to
Sort By:
Pageof 21
The American Journal of Pathology|October 29, 2004
Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brainCarina C Ferrari, Amaicha M Depino, Federico Prada, et al.Brain : a Journal of Neurology|January 10, 2016
Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathologyAdrian Olmos-Alonso, Sjoerd T T Schetters, Sarmi Sri, et al.Scientific Reports|May 14, 2016
CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nervesAnna Martínez-Muriana, Renzo Mancuso, Isaac Francos-Quijorna, et al.Biological Psychiatry|September 20, 2008
Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative diseaseColm Cunningham, Suzanne Campion, Katie Lunnon, et al.Progress in Brain Research|December 4, 2003
Morphology and physiology of primate M- and P-cellsLuiz Carlos Silveira, Cézar A Saito, Barry B Lee, et al.Journal of Neuroinflammation|April 9, 2023
Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion diseaseMarta Vicente-Rodríguez, Renzo Mancuso, Alba Peris-Yague, et al.Acta Neuropathologica Communications|February 24, 2019
Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer's diseaseSarmi Sri, Chrysia-Maria Pegasiou, Chantal Abbigail Cave, et al.Neurobiology of Disease|May 11, 2007
MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changesKerry A Broom, Daniel C Anthony, John P Lowe, et al.Journal of Affective Disorders|July 10, 2002
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodiesClive Ballard, Mary Johnson, Margaret Piggott, et al.Dementia and Geriatric Cognitive Disorders|February 22, 2011
A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's diseaseAlistair Burns, Elaine Perry, Clive Holmes, et al.Pageof 21